Gil Gilad
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
- Oncology 8
- Neutropenia and Cancer Infections 4
-
- Acute Lymphoblastic Leukemia research 7
- Reproductive Biology and Fertility 2
- Co-authors
- Isaac Yaniv (8 shared papers)Itzhak Levy (4 shared papers)Meirav Mor (1 shared paper)Liora Kornreich (1 shared paper)Sarah Elitzur (13 shared papers)Shai Izraeli (10 shared papers)Galia Avrahami (8 shared papers)Nira Arad‐Cohen (8 shared papers)
- Journals
- Pediatric Blood & Cancer (4 papers)British Journal of Haematology (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)Journal of Fungi (2 papers)International Journal of Clinical Oncology (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Gil Gilad
21 papers receiving 298 citations
Peers
Comparison fields: 5 of 54
- Infectious Diseases 122
- Hematology 57
- Internal Medicine 16
- Oncology 109
- Epidemiology 120
Countries citing papers authored by Gil Gilad
This map shows the geographic impact of Gil Gilad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Gilad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Gilad more than expected).
Fields of papers citing papers by Gil Gilad
This network shows the impact of papers produced by Gil Gilad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Gilad. The network helps show where Gil Gilad may publish in the future.
Co-authors
The 25 scholars most cited alongside Gil Gilad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 107 | |
| 2 | 2016 | 28 | |
| 3 | 2007 | 21 | |
| 4 | 2019 | 21 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 18 | |
| 7 | 2020 | 12 | |
| 8 | 2017 | 11 | |
| 9 | 2019 | 11 | |
| 10 | 2017 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2015 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2021 | 2 | |
| 20 | Delivery of the very low birthweight breech: what is the best way for the baby? | 1996 | 2 |
About Gil Gilad
Gil Gilad is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Infectious Diseases, Pediatrics, Perinatology and Child Health and Hematology, having authored 23 papers that have together received 302 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Fungal Infections and Studies (5 papers), Antifungal resistance and susceptibility (5 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Neutropenia and Cancer Infections (4 papers), Chronic Lymphocytic Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Reproductive Biology and Fertility (2 papers). The work is most often cited by research in Infectious Diseases (122 citations), Hematology (57 citations), Internal Medicine (16 citations), Oncology (109 citations) and Epidemiology (120 citations). Gil Gilad has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Isaac Yaniv, Itzhak Levy, Meirav Mor, Liora Kornreich, Sarah Elitzur, Shai Izraeli, Galia Avrahami, Nira Arad‐Cohen, Ronit Elhasid and Ronit Nirel. Their work appears in journals such as Pediatric Blood & Cancer, British Journal of Haematology, Journal of Pediatric Hematology/Oncology, Journal of Fungi and International Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.